In Vivo Molecular Imaging 2011

IN VIVO MOLECULAR IMAGING AS AN ESSENTIAL
TOOL IN DRUG DISCOVERY AND DEVELOPMENT

Keynote Presentation: Imaging Biomarkers in Drug Development

Jeffrey Evelhoch, Ph.D., Vice President, Exploratory & Translational Sciences; Head, Imaging, Merck Research Laboratories
Successfully Integrating Molecular Imaging into Drug Discovery and Development
Thomas Krucker, Ph.D., Head, Molecular Imaging, Global Imaging Group, Novartis Institutes for Biomedical Research, Inc. (NIBRI)
The Expanding Role of Imaging for Assessment of Proof of Concept in Pharma- and Bio-Therapeutic Drug Discovery and Development
Thomas Bocan, Ph.D., Senior Director, Head of BioImaging Center, PharmaTherapeutics Research & Development, Pfizer, Inc.

TRANSLATIONAL APPROACHES IN PRE-CLINICAL
IN VIVO MOLECULAR IMAGING RESEARCH

Keynote Presentation: Molecular Imaging for Selection and Monitoring of Therapies in Oncology

Gelovani Juri, M.D., Ph.D., President, Academy of Molecular Imaging; Professor and Chairman, Experimental Diagnostic Imaging, University of Texas MD Anderson Cancer Center
Novel PET Tracers as Translational Tools in Drug Discovery and Development
Dennis McCarthy, Ph.D., Director, Early Development, AstraZeneca R&D

MOLECULAR IMAGING UTILIZATION
IN VARIOUS THERAPEUTIC AREAS

Preclinical Biomarkers for Translational Neuroscience: Examples from Drug Discovery
Donna L. Maier, Ph.D., Associate Director - Biology, BrainCells Inc.
Use of Functional, Structural and Molecular in vivo Imaging as Translational Tools to Assess Joint Disease
Lawrence de Garavilla, M.S., Ph.D., Research Fellow, ImmunoPharmacology, Johnson & Johnson
Characterization of a Water Soluble Z DEVD Aminoluciferin Probe for the Non Invasive Bioluminescent Imaging of Apoptosis in vivo
Jonathan A. Hickson, Ph.D., Senior Scientist II, Pharmacology, Cancer Research, Global Pharmaceutical Research & Development, Abbo